A Single Arm Trial of Continuous 24-week-intervention with Designated Treatment Application for Essential Hypertension in addition to hypertension treatment in accordance with guideline

A Single Arm Trial of Continuous 24-week-intervention with Designated Treatment Application for Essential Hypertension in addition to hypertension treatment in accordance with guideline - A Single Arm Trial of Continuous 24-week-intervention with Designated Treatment Application for Essential Hypertension in addition to hypertension treatment in accordance with guideline

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000035079

Enrollment

Registered

2018-11-30

Start date

2018-03-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Essential Hypertension

Interventions

Use the application in addition to standard therapy of hypertension with life-style modification

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with mild to moderate essential hypertension using smartphones who are or are not under treatment of hypertension(drugs, etc.)

Exclusion criteria

Exclusion criteria: Patients with severe hypertension, a history of secondary hypertension, cardiovascular / cerebrovascular events, etc

Design outcomes

Primary

Measure	Time frame
Change in mean systolic blood pressure from baseline at Week 16	—

Countries

Japan

Contacts

Public ContactTaeko Kikuchi

CureApp, Inc. Regulatory and Clinical Affairs

t-kikuchi@cureapp.jp03-6231-0183

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026